API
WST icon

Advisor Partners II’s West Pharmaceutical WST Stock Holding History

Advisor Partners II’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$3.28M Sell
8,732
-120
-1% -$46.4K 0.13% 160
2023
Q2 		$3.39M Buy
8,852
+4
+0% +$1.43K 0.16% 124
2023
Q1 		$3.07M Sell
8,848
-213
-2% -$62.2K 0.17% 119
2022
Q4 		$2.13M Buy
9,061
+5,950
+191% +$1.41M 0.13% 165
2022
Q3 		$766K Buy
+3,111
New +$948K 0.06% 340

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Advisor Partners II's WST Position: Q3 2023 in Review

Advisor Partners II reduced its West Pharmaceutical (WST) stake by 1.4% in Q3 2023, selling an estimated $46.4K and leaving 8,732 shares worth $3.28M. The position accounts for 0.13% of the portfolio, ranked #160.

Advisor Partners II first reported a position in WST in Q3 2022 and has held it in 5 quarters since. The position peaked at $3.39M in Q2 2023. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • Advisor Partners II held 8,732 shares of West Pharmaceutical worth $3.28M as of Q3 2023.
  • Advisor Partners II sold 120 West Pharmaceutical shares in Q3 2023, an estimated $46.4K.
  • West Pharmaceutical made up 0.13% of Advisor Partners II's portfolio in Q3 2023, its #160 holding.
  • Advisor Partners II first reported a position in West Pharmaceutical in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's West Pharmaceutical position peaked at $3.39M in Q2 2023.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.